Search
Friday 26 June 2015
  • :
  • :

Pre-Market News Analysis on: Zayo Group Holdings (NYSE:ZAYO), Lincoln National (NYSE:LNC), Western Refining, (NYSE:WNR), Esperion Therapeutics (NASDAQ:ESPR)

On Wednesday, Zayo Group Holdings Inc (NYSE:ZAYO)’s shares declined -1.98% to $27.80.

Global bandwidth infrastructure provider Zayo Group (ZAYO) declared that it has been recognized at the City of London’s Considerate Contractor Scheme awards for its work across the City during the past 12 months. Zayo won gold in the Streetworks category, making 2015 the third successive year the company has been honoured.

The Considerate Contractor Scheme, founded by the City of London in 1987, works to encourage building and civil engineering contractors working in the City to operate in a safe and considerate manner, taking into account other users. Winners are judged on a code of good practice, which incorporates public comments. The code requires that they operate with care, cleanliness, considerateness and cooperativeness, taking into account comments from members of the public.

Zayo Group Holdings, Inc., through its auxiliaries, provides bandwidth infrastructure solutions for the communications industry in the United States and Europe. The company operates in three segments: Physical Infrastructure, Lit Services, and Other. The Physical Infrastructure segment provides dark fiber, fiber-to-the-tower and small cell mobile infrastructure, and colocation and interconnection services for carriers and other communication service providers, Internet service providers, wireless service providers, media and content companies, large enterprises, and other companies.

Lincoln National Corporation (NYSE:LNC)’s shares dropped -0.03% to $60.87.

Lincoln Financial Group (LNC) declared the next generation of its Lincoln AssetEdge® Variable Universal Life (VUL) insurance offering, featuring expanded investment options for tax-efficient cash accumulation with downside protection, and supplemental income potential, as well as life insurance protection.

In addition to offering clients an income tax-free death benefit and more than 80 market-driven variable investment options from the Lincoln Elite Series of Funds for maximum growth potential, Lincoln AssetEdge® VUL now offers three indexed accounts for moderate growth potential with guaranteed downside protection, and a fixed account for more conservative, predictable growth. Clients have the ability to adjust investment allocations over time to align with changing needs and financial goals.

Lincoln National Corporation, through its auxiliaries, engages in multiple insurance and retirement businesses in the United States. It operates through Annuities, Retirement Plan Services, Life Insurance, and Group Protection segments.

At the end of Wednesday’s trade, Western Refining, Inc. (NYSE:WNR)‘s shares dipped -1.96% to $43.44.

Western Refining, Inc. (WNR) declared that it has filed a universal shelf registration statement on Form S-3 with the United States Securities and Exchange Commission (“SEC”). While WNRL has no immediate plans to issue securities under the registration statement, the registration statement is intended to provide the Company with flexibility to access the public capital markets in order to respond to business opportunities as they arise. Although the registration statement has been filed with the SEC, it has not yet become effective.

Following the effectiveness of the shelf registration statement, WNRL may periodically offer one or more of the registered securities in amounts, at prices, and on terms to be declared when, and if, the securities are offered. The terms of any securities offered under the registration statement, and the intended use of the net proceeds resulting therefrom, will be established at the times of the offerings and will be described in prospectus supplements filed with the SEC at the times of the offerings.

A registration statement regarding these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release is not an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Western Refining, Inc. operates as an independent crude oil refiner and marketer of refined products. The company operates in four segments: Refining, NTI, WNRL, and Retail. The Refining segment owns and operates two refineries that process crude oil and other feed stocks primarily into gasoline, diesel fuel, jet fuel, and asphalt; and markets refined products to various customers, counting wholesale distributors and retail chains.

Esperion Therapeutics Inc (NASDAQ:ESPR), ended its Wednesday’s trading session with 3.77% gain, and closed at $84.02.

Esperion Therapeutics Inc (ESPR) , an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, recently declared the appointment of Scott Braunstein, M.D. as a Class III Director, with a term expiring at the 2016 annual meeting of stockholders.

Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. Its products comprise ETC-1002, an oral molecule therapy that is in Phase 2b clinical trials to treat patients with hypercholesterolemia, in addition to to lower levels of LDL-cholesterol, and avoid various side effects associated with LDL-cholesterol lowering therapies.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *